Summit Trail Advisors LLC lessened its position in shares of Genpact Limited (NYSE:G – Free Report) by 9.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,457 shares of the business services provider’s stock after selling 2,111 shares during the quarter. Summit Trail Advisors LLC’s holdings in Genpact were worth $802,000 as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. Dimensional Fund Advisors LP raised its position in shares of Genpact by 34.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,326,054 shares of the business services provider’s stock valued at $107,065,000 after buying an additional 847,249 shares in the last quarter. Pzena Investment Management LLC increased its stake in Genpact by 130.3% during the second quarter. Pzena Investment Management LLC now owns 1,163,870 shares of the business services provider’s stock worth $37,465,000 after acquiring an additional 658,560 shares during the last quarter. Los Angeles Capital Management LLC purchased a new stake in Genpact during the third quarter valued at approximately $19,779,000. Tandem Investment Advisors Inc. bought a new stake in shares of Genpact in the 3rd quarter valued at approximately $17,025,000. Finally, Vulcan Value Partners LLC boosted its holdings in shares of Genpact by 22.2% in the 2nd quarter. Vulcan Value Partners LLC now owns 1,567,428 shares of the business services provider’s stock worth $50,456,000 after purchasing an additional 284,842 shares during the period. Institutional investors own 96.03% of the company’s stock.
Genpact Stock Performance
Shares of Genpact stock opened at $46.64 on Tuesday. The company has a market capitalization of $8.23 billion, a PE ratio of 12.76, a P/E/G ratio of 1.59 and a beta of 1.13. The company has a 50-day simple moving average of $40.38 and a two-hundred day simple moving average of $36.56. Genpact Limited has a one year low of $30.23 and a one year high of $47.98. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 1.85.
Genpact Announces Dividend
Analyst Ratings Changes
G has been the subject of a number of analyst reports. Needham & Company LLC raised their price target on Genpact from $42.00 to $55.00 and gave the stock a “buy” rating in a research report on Monday, November 11th. TD Cowen lifted their price target on shares of Genpact from $40.00 to $45.00 and gave the stock a “hold” rating in a research note on Friday, November 8th. JPMorgan Chase & Co. upped their price target on shares of Genpact from $35.00 to $43.00 and gave the company a “neutral” rating in a report on Friday, September 6th. BMO Capital Markets raised their price objective on shares of Genpact from $38.00 to $42.00 and gave the stock a “market perform” rating in a research note on Monday, August 12th. Finally, Robert W. Baird upped their target price on Genpact from $44.00 to $48.00 and gave the company a “neutral” rating in a research note on Friday, November 8th. Eight analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $42.33.
Check Out Our Latest Analysis on Genpact
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Stories
- Five stocks we like better than Genpact
- What is the Hang Seng index?
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- What are earnings reports?
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Discover the 3 Best Performing Stocks That Went Public in 2024
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.